Login

Financial Snapshot

Revenue
TTM
$825.4M
Gross Margin
TTM
70.74%
Net Income
TTM
-$60.01M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
286.6%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
435.2M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$4.423M

Stock Price

Loading...
Market Cap: $392.9 Million

About Orthofix Medical Inc

Orthofix Medical Inc (NASDAQ: OFIX) is a global medical technology company headquartered in Lewisville, Texas, that designs and sells medical devices and biologics for musculoskeletal conditions. Revenue comes from transactional sales of spinal hardware, bone growth stimulators, biologics, and limb reconstruction products sold through commercial sales channels to hospitals, surgeons, and third-party payors. The company operates two reported segments: Global Spine, which provides implantable spinal devices, biologics, enabling technologies, and bone growth therapies; and a separate limb reconstruction business. Customers include physicians, hospitals, and third-party payors. Bone growth stimulator devices are currently classified as FDA Class III devices, though an FDA panel has recommended reclassification to Class II, which the company's FY2025 10-K filing (accession 000119312526065189, filed 2026-02-24) identifies as a risk that could increase competition and negatively affect sales of those products.

Revenue model
Transactional product sales of spinal implants, bone growth stimulators, biologics, and limb reconstruction devices through dedicated commercial sales channels to hospitals and physicians.
Products and services
Spinal hardware implants, bone growth stimulators (electromagnetic), biologics, enabling technologies, regenerative solutions, and limb reconstruction devices.
Customers and end markets
Physicians, hospitals, and third-party payors. End markets include spinal surgery, bone healing, and limb reconstruction.
Value-chain role
Medical device manufacturer and commercial distributor of orthopedic and spine implants, biologics, and bone growth stimulation devices.
Geographic exposure
Global operations with headquarters in Lewisville, Texas. International commercial presence referenced in Global Spine segment strategy as of the FY2025 10-K filing.

Source: SEC 10-K, filed 2026-02-24

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories /entities/zyxiq AxoGen Inc Cue Health Inc. Vicarious Surgical Inc Inogen Inc IRadimed Corp Sight Sciences Inc SURMODICS INC ZimVie Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support